Ventilatory Efficiency Testing As Prognostic Value in Patients with Pulmonary Hypertension

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2012 Jun 9

PMID 22676304

Citations 34

Authors

Martin Schwaiblmair

Christian Faul

Wolfgang von Scheidt

Thomas M Berghaus

Affiliations

Soon will be listed here.

Abstract

Background: Increased ventilatory response has been shown to have a high prognostic value in patients with chronic heart failure. Our aim was therefore to determine the ventilatory efficiency in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension by cardiopulmonary exercise testing (CPET) identifying PH-patients with increased risk for death within 24 months after evaluation.

Methods: 116 patients (age: 64 ± 1 years) with a mean pulmonary arterial pressure of 35 ± 1 mmHg underwent CPET and right heart catheterization. During a follow-up of 24 months, we compared the initial characteristics of survivors (n = 87) with nonsurvivors (n = 29).

Results: Significant differences (p ≤ 0.005) between survivors and nonsurvivors existed in ventilatory equivalents for oxygen (42.1 ± 2.1 versus 56.9 ± 2.6) and for carbon dioxide (Ve/VCO2) (47.5 ± 2.2 versus 64.4 ± 2.3). Patients with peak oxygen uptake ≤ 10.4 ml/min/kg had a 1.5-fold, Ve/VCO2 ≥ 55 a 7.8-fold, alveolar-arterial oxygen difference ≥ 55 mmHg a 2.9-fold, and with Ve/VCO2 slope ≥ 60 a 5.8-fold increased risk of mortality in the next 24 months.

Conclusions: Our results demonstrate that abnormalities in exercise ventilation powerfully predict outcomes in PH. Consideration should be given to add clinical guidelines to reflect the prognostic importance of ventilatory efficiency parameters in addition to peak VO2.

Citing Articles

Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.

Tarras E, Singh I, Kreiger J, Joseph P J Clin Med. 2025; 14(3).

PMID: 39941482 PMC: 11818252. DOI: 10.3390/jcm14030804.

Effects of combined aerobic, resistance and inspiratory training in patients with pulmonary hypertension: A systematic review.

Kourek C, Zachariou A, Karatzanos E, Antonopoulos M, Soulele T, Karabinis A World J Crit Care Med. 2024; 13(2):92585.

PMID: 38855278 PMC: 11155510. DOI: 10.5492/wjccm.v13.i2.92585.

The association between cardiopulmonary exercise testing and postoperative outcomes in patients with lung cancer undergoing lung resection surgery: A systematic review and meta-analysis.

Arbee-Kalidas N, Moutlana H, Moodley Y, Kebalepile M, Motshabi Chakane P PLoS One. 2023; 18(12):e0295430.

PMID: 38060569 PMC: 10703215. DOI: 10.1371/journal.pone.0295430.

The Current Role of Cardiopulmonary Exercise Test in the Diagnosis and Management of Pulmonary Hypertension.

Pezzuto B, Agostoni P J Clin Med. 2023; 12(17).

PMID: 37685532 PMC: 10487723. DOI: 10.3390/jcm12175465.

Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension.

Tobita K, Goda A, Teruya K, Nishida Y, Takeuchi K, Kikuchi H J Am Heart Assoc. 2023; 12(11):e026890.

PMID: 37260024 PMC: 10382004. DOI: 10.1161/JAHA.122.026890.

References

Witte K, Thackray S, Nikitin N, Cleland J, Clark A . Pattern of ventilation during exercise in chronic heart failure. Heart. 2003; 89(6):610-4. PMC: 1767691. DOI: 10.1136/heart.89.6.610. View

Gitt A, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M . Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002; 106(24):3079-84. DOI: 10.1161/01.cir.0000041428.99427.06. View

McEvoy J, Jones N . Arterialized capillary blood gases in exercise studies. Med Sci Sports. 1975; 7(4):312-5. DOI: 10.1249/00005768-197500740-00014. View

Chua T, Clark A, Amadi A, Coats A . Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 1996; 27(3):650-7. DOI: 10.1016/0735-1097(95)00523-4. View

JOHNSON Jr R . Gas exchange efficiency in congestive heart failure. Circulation. 2000; 101(24):2774-6. DOI: 10.1161/01.cir.101.24.2774. View

Yasunobu Y, Oudiz R, Sun X, Hansen J, Wasserman K . End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest. 2005; 127(5):1637-46. DOI: 10.1378/chest.127.5.1637. View

Ting H, Sun X, Chuang M, Lewis D, Hansen J, Wasserman K . A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension. Chest. 2001; 119(3):824-32. DOI: 10.1378/chest.119.3.824. View

Chua T, Ponikowski P, Harrington D, Anker S, Clark A, Poole-Wilson P . Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 1997; 29(7):1585-90. DOI: 10.1016/s0735-1097(97)00078-8. View

Narkiewicz K, Pesek C, van de Borne P, Kato M, Somers V . Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation. 1999; 100(3):262-7. DOI: 10.1161/01.cir.100.3.262. View

10.

Sun X, Hansen J, Oudiz R, Wasserman K . Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001; 104(4):429-35. DOI: 10.1161/hc2901.093198. View

11.

Guazzi M, Myers J, Arena R . Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol. 2005; 46(10):1883-90. DOI: 10.1016/j.jacc.2005.07.051. View

12.

Davies L, Francis D, Piepoli M, Scott A, Ponikowski P, Coats A . Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification. Heart. 2000; 83(2):147-51. PMC: 1729303. DOI: 10.1136/heart.83.2.147. View

13.

Riley M, Porszasz J, Engelen M, Brundage B, Wasserman K . Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans. Eur J Appl Physiol. 2000; 83(1):63-70. DOI: 10.1007/s004210000240. View

14.

Nagaya N, Shimizu Y, Satoh T, Oya H, Uematsu M, Kyotani S . Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart. 2002; 87(4):340-5. PMC: 1767070. DOI: 10.1136/heart.87.4.340. View

15.

Humbert M, McLaughlin V . The 4th World Symposium on Pulmonary Hypertension. Introduction. J Am Coll Cardiol. 2009; 54(1 Suppl):S1-S2. DOI: 10.1016/j.jacc.2009.04.013. View

16.

Arena R, Myers J, Aslam S, Varughese E, Peberdy M . Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J. 2004; 147(2):354-60. DOI: 10.1016/j.ahj.2003.07.014. View

17.

Lewis N, Banning A, Cooper J, Sundar A, Facey P, Evans W . Impaired matching of perfusion and ventilation in heart failure detected by 133xenon. Basic Res Cardiol. 1996; 91 Suppl 1:45-9. DOI: 10.1007/BF00810523. View

18.

Kleber F, Vietzke G, Wernecke K, Bauer U, Opitz C, Wensel R . Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation. 2000; 101(24):2803-9. DOI: 10.1161/01.cir.101.24.2803. View

19.

Habedank D, Reindl I, Vietzke G, Bauer U, Sperfeld A, Glaser S . Ventilatory efficiency and exercise tolerance in 101 healthy volunteers. Eur J Appl Physiol Occup Physiol. 1998; 77(5):421-6. DOI: 10.1007/s004210050354. View

20.

Oudiz R, Barst R, Hansen J, Sun X, Garofano R, Wu X . Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol. 2005; 97(1):123-6. DOI: 10.1016/j.amjcard.2005.07.129. View